Interleukin 7 induces CD4+ T cell-dependent tumor rejection. - Wikidata - wikimedia - TriplyDB

Interleukin 7 induces CD4+ T cell-dependent tumor rejection.

Interleukin 7 induces CD4+ T cell-dependent tumor rejection.

http://www.wikidata.org/entity/Q36230708

about

Gene Therapy for Pediatric Cancer: State of the Art and Future Perspectives Interleukin-7. Biology and implications for dermatology Chemo-immunotherapy with oxaliplatin and interleukin-7 inhibits colon cancer metastasis in mice Tumor mouse model confirms MAGE-A3 cancer immunotherapeutic as an efficient inducer of long-lasting anti-tumoral responses.Antitumor effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts.Reversal of acute myelogenous leukemia in humanized SCID mice using a novel adoptive transfer approach Dysregulated recruitment of the histone methyltransferase EZH2 to the class II transactivator (CIITA) promoter IV in breast cancer cells.Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism Gene therapy for paediatric leukaemia.IL2 treatment for cancer: from biology to gene therapy Hypoxic tumor cell death and modulation of endothelial adhesion molecules in the regression of granulocyte colony-stimulating factor-transduced tumors.Local and systemic response of mice to interferon-alpha 1-transfected Friend leukemia cells.Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration.Vaccines in cancer: GVAX, a GM-CSF gene vaccine.Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma Genes for interleukin 7 are transcribed in leukemic cell subsets of individuals with chronic lymphocytic leukemia.Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines.Tumor-infiltrating T lymphocytes: friends or foes?Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming Cancer immunotherapy: potential involvement of mediators.Increased sensitivity to apoptotic stimuli in c-abl-deficient progenitor B-cell lines IL-7 signaling imparts polyfunctionality and stemness potential to CD4(+) T cells.Multiple roles for CD4+ T cells in anti-tumor immune responses.Immunotherapy and gene therapy for genitourinary malignancies.Novel targets for natural killer/T-cell lymphoma immunotherapy.Genetically engineered tumor vaccines.Considerations for the use of cytokine-secreting tumor cell preparations for cancer treatment.Retroviral vectors for use in human gene therapy for cancer, Gaucher disease, and arthritis.Interleukin-7: biology and potential clinical applications.Cancer vaccines: the perspective of the Cancer Immunology Branch, NCI.Retroviral vector-mediated cytokine-gene transfer into tumor cells.The potential applications of gene transfer in the treatment of patients with cancer: a concise review.Cytokine gene therapy of cancer using interleukin-12: murine and clinical trials.Tumor immunotherapy by vaccination with cytokine gene transfected cells.Retrovirus-mediated gene transfer of the human gamma-IFN gene: a therapy for cancer.Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma A human recombinant IL-7/HGFβ hybrid cytokine enhances antitumor immunity in mice.Comparison of the potential therapeutic effects of interleukin 2 or interleukin 4 secretion by a single tumour.Antitumor and antimetastatic activity of interleukin 12 against murine tumors.

P2860

Q24792778-5AD48570-4916-4EDD-BF35-B3ACBF03758C Q28292184-C26D6805-2717-45EF-91AF-6E902CB8698D Q28538913-4AA5E6A4-0B8F-49F8-942B-43D90822E861 Q33617905-3CA59CBA-1397-4EC9-8918-FABEAE2C0205 Q33905476-C260F14D-74BA-4329-A00F-11C75802DF09 Q34183838-E56425E3-75B4-4462-BBDA-68CF9B8280E7 Q34259906-6BF8B1BE-1F8B-4B55-B448-03F002B93CF1 Q34334817-9B0742A8-B083-4130-9F21-29DED95B1058 Q34392868-E5DA739C-896E-45CD-96D8-F5E425D7DAA3 Q34451905-D7319D05-5AAD-4B6D-BA3C-0A959EB64D70 Q35565971-A81F1A8B-F69E-4C0B-A3BB-B6AF07BF67BF Q35774179-5EE7565E-BCBC-4B55-8487-FEFA06F0EB78 Q35796105-42D53FA9-949C-4D90-8D2B-2CC1C8CE21A9 Q36081142-1BAD5525-B55E-4485-82DF-0FBABA8C6F97 Q36198632-A5D8BE28-9012-4EBB-B8E0-7E7325A6ED51 Q36199032-546F689E-F308-491A-9BD1-55FD5C716E9E Q36361584-DABB5D9C-08C0-40CF-87D7-FB9499FED00A Q36368444-2771E81C-FCB3-4929-9064-692EFB84C658 Q36381918-88226F0A-7970-4198-A005-70F52F69A9B2 Q36446446-397D902A-0D8E-4F44-9AF3-D0D03829FF86 Q36628188-B68D1A35-6C05-4E78-89EF-243D24F3922B Q36688513-7C743EB2-3A8D-4BBF-B846-6EE20DB0E388 Q37078985-43438F07-98A1-46D2-8D1E-9ECA270A5EE7 Q37118150-14C095E4-C168-4DBB-9BFE-807ABB9A9F05 Q38168574-354FD122-E2E6-47E7-A392-98F4CE6A8E39 Q38661106-E7CA9FD3-AAF2-4228-9E0D-7F7800285467 Q40489810-23D4741A-1E70-4DCF-9E02-0C1F69587DAF Q40603524-E7C8515D-7988-4D19-80D2-B1ED155A4F9F Q40624060-CA15E31A-95EA-4EB3-8666-DE06BDED2349 Q40822486-5E3CCFC7-A17C-4E7C-9EA8-CA90E9EE0532 Q40844506-DAE572E2-172F-456C-9C9E-B7A69ACF3043 Q40903182-F512072F-64F6-4D00-821C-41F1192128A8 Q41020855-6A3FECBE-046C-4813-B97D-01AE54658853 Q41261328-53FEF592-C8F4-40BA-967E-DAA4C5B2A14F Q41455939-6BB4A3C2-0ED2-4846-AA3C-DAA7B0030BB6 Q41466648-52A359D1-295B-4545-AF30-720CEE616FB1 Q41546511-39015391-1EEC-431D-9062-0D3015522E7B Q41547622-634C1455-4879-48BB-BCC2-EF00F13740C9 Q41892367-FF9312EC-8A19-4CE8-BB4A-F6D71DE7298B Q41906195-4F4BCD1B-36B7-40D2-BE28-9794E9F7B8C2

P2860

Interleukin 7 induces CD4+ T cell-dependent tumor rejection.

http://www.wikidata.org/entity/Q36230708

description

1991 nî lūn-bûn

@nan

1991年の論文

@ja

1991年論文

@yue

1991年論文

@zh-hant

1991年論文

@zh-hk

1991年論文

@zh-mo

1991年論文

@zh-tw

1991年论文

@wuu

1991年论文

@zh

1991年论文

@zh-cn

name

Interleukin 7 induces CD4+ T cell-dependent tumor rejection.

@ast

Interleukin 7 induces CD4+ T cell-dependent tumor rejection.

@en

type

label

Interleukin 7 induces CD4+ T cell-dependent tumor rejection.

@ast

Interleukin 7 induces CD4+ T cell-dependent tumor rejection.

@en

prefLabel

Interleukin 7 induces CD4+ T cell-dependent tumor rejection.

@ast

Interleukin 7 induces CD4+ T cell-dependent tumor rejection.

@en

P1433

Q36230708-F4971B07-E993-4D71-9669-46A8D0DC9C48

P1476

Q36230708-853D7466-B574-46F9-AEFF-2CE24ACA35F0

P2093

Q36230708-2B5D9669-7918-4013-9729-5E42B84D2CFC

Q36230708-4D11A7D3-8BCE-4C0D-AB3D-58BFF7957E84

Q36230708-6E531F4A-99BA-43BC-82E2-A73EFEC7E927

Q36230708-820A6C84-6B7A-4921-B06F-B62CDC15DB8A

P2860

Q36230708-01F58106-C2FD-40CA-AF74-EAC3DE576435

Q36230708-0246B609-B75E-4912-A631-4BE2A0BDCB69

Q36230708-05D579B4-B8CB-4126-A9F9-B035905F00FD

Q36230708-16A8844D-7C43-4F42-8861-361E5BD6203B

Q36230708-23DF1D57-EE18-4FAE-ADB6-6B5347D289D8

Q36230708-2FC69FAB-69CF-481B-B2BD-C18A943DDB2D

Q36230708-4848EC50-21FE-4C05-919D-75503D30F31C

Q36230708-4DD2CBAF-EFE4-4DD9-AF5C-4E425B683A51

Q36230708-52AE6F2E-45CC-4A35-AFDF-3E4AEF127AD5

Q36230708-6B062205-BF69-488C-80FE-D4AB984D3A56

P304

Q36230708-DA97CAE6-7E21-47AE-8567-33EF6B1D5B9E

P31

Q36230708-D00EDA9F-4962-4FD2-9948-B0E2504854AB

P356

Q36230708-AA01D2AB-DDF8-4848-A05D-A6A5B78CA497

P407

Q36230708-493491D1-3D77-4477-BA02-8F0784317038

P433

Q36230708-DF2FAB97-A0C1-4202-A2BC-46DE2AF652F2

P478

Q36230708-F7DF84EA-55CA-4B2D-940E-94C9E4E56B0C

P577

Q36230708-C38BEB3F-E9CE-435F-B76A-51F976B0EB4F

P5875

Q36230708-82748A4D-B573-4153-9B53-364BF2AE82C5

P698

Q36230708-03FE5FFD-81CA-45D2-9F50-F5E3A7621DB3

P932

Q36230708-6D51A7F5-AFD0-47F9-A1C3-3106378D94C2

P356

P1433

Journal of Experimental Medicine

P1476

Interleukin 7 induces CD4+ T cell-dependent tumor rejection.

@en

P2093

Blankenstein T

http://www.w3.org/2001/XMLSchema#string

Diamantstein T

http://www.w3.org/2001/XMLSchema#string

Dorsch M

http://www.w3.org/2001/XMLSchema#string

Hock H

http://www.w3.org/2001/XMLSchema#string

P2860

Stimulation of B-cell progenitors by cloned murine interleukin-7

Correction of the genetic defect in hepatocytes from the Watanabe heritable hyperlipidemic rabbit.

Immunoglobulin gene expression in transformed lymphoid cells.

Interleukin 7 is a T-cell growth factor.

Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity

Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors

Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.

Antibody to the murine type 3 complement receptor inhibits T lymphocyte-dependent recruitment of myelomonocytic cells in vivo

Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells.

P304

1291-1298

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.174.6.1291

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

174

http://www.w3.org/2001/XMLSchema#string

P577

1991-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277500769

http://www.w3.org/2001/XMLSchema#string

P698

1683890

http://www.w3.org/2001/XMLSchema#string

P932

2119049

http://www.w3.org/2001/XMLSchema#string